Optimal management of asymptomatic generalized rectal cancer is still the matter of debate. the aim of the study was to review stage IV rectal cancer patients who were treated in our clinic since 2000 till 2008 in order to evaluate the effectiveness of surgery. material and methods. Fifty-two generalized rectal cancer patients treated with elective resection of primary tumor were identified. Patients' age, sex, duration of hospital stay, modality of surgery, complications, postoperative mortality rate and survival rate were assessed. Results. Median survival was 16.3 months. Postoperative complications occurred in 29% patients. Postoperative mortality rate was 1.9%. Conclusions. In properly selected group of patients elective resection of primary tumor may cause low mortality rate and acceptable morbidity rate. This surgical modality allows to avoid potential complications of tumor local growth.
Rectal cancer constitutes a significant health problem in the modern world. It is estimated that there are approx. million new cases each year worldwide, and half a million deaths due to it (1) . In Poland, in 2008, 14,441 new colorectal cancer cases and 9,915 deaths were reported (2) . Despite the undertaken efforts aimed at early disease detection, the introduced screening tests, educational activities and increasing awareness in the society, in approx. 20% of patients colorectal cancer is diagnosed at stage IV of disease advancement. In this group, 80-90% of patients have nonresectable lesions, and the recorded 5-year survival stands at approx. 8% (3).
The aim of the study was the evaluation of the results of surgical treatment of patients with rectal cancer at stage IV of clinical advancement, performed at the Department of at the Department of Surgical Oncology, Pomeranian Medical University in Szczecin, there were treated 440 patients with rectal cancer. The study group of 52 was selected based on the available medical documentation, and the selection criteria included the stage IV of clinical advancement and undergone planned rectal resection.
The analysed parameters include the patient gender, period of hospitalisation, type of performed procedure, complications and early mortality. The data concerning long-term survival were obtained from questionnaires sent by the patients and their families, the registry offices and the cemetery administration records. Long-term survival was analysed with use of Kaplan-Meier method.
RESULTS
The retrospective study enrolled 52 patients with disseminated rectal cancer who had undergone planned resection of this organ. The mean age of patients was 62 (range: 25-84). Males constituted 71% (n = 37) and females -29% (n = 15) of the study group. Stage IV of clinical advancement was determined by imaging techniques in 40 patients, and by laparotomy in 12 of them. 3 patients had been subject to pre-operative radiation therapy.
Metastatic lesions in liver only were found in 42 (80.7%) of treated patients, while in 7 (13.4%) metastases affected more than one organ and in 5 peritoneal canceration was seen.
The majority, i.e. 37 of patients had multiple metastases to the liver, while single metastases were found in 12 patients. The characteristics of liver metastases were presented in tab. 1.
erative complications were seen in 29% of patients, of which the most common one was surgical wound infection -tab. 3. Three patients developed during the resection a marked haemorrhage requiring pelvic setonage and repeat surgery. Survival in the group of patients at stage IV of clinical advancement of rectal cancer post resection surgery is presented in fig. 2 . The median survival was 16.3 months.
DISCUSSION
In the era of evidence-based medicine and increasingly more stringent guidelines for The patients had undergone planned surgery. Typical resection procedures had been performed, as employed in the treatment of rectal cancer, in combination with adequate mesorectal resection. In two patients, due to familial polyposis, restorative proctocolectomy was performed. Figure 1 presents the share of individual types of surgical procedures employed in the treatment of the study group.
In 9 (17.3%) of patients, synchronous hepatectomy was performed. The analysis of further patients' fate revealed that 6 more patients (11.5%) were subject to subsequent metachronic hepatectomy. The characteristics of performed hepatectomies were presented in tab. 2.
The mean hospitalisation period was 15 days (range: 6-37).
Perioperative mortality in the study group was 1.9% -1 patient who died on day 23 post hospital discharge, yet no information on the cause of death could be obtained. Early post-op- Kaplan-Meier treatment methods of cancer patients, the surgeon still faces a dilemma of selecting the approach for patients at stage IV of clinical advancement of colorectal cancer. The role of surgery in patients with complications associated with the tumour (haemorrhage, perforation, obstruction) is unquestionable, while the application of surgery in asymptomatic patients or those exhibiting mild symptoms at stage IV of colorectal cancer remains a subject of discussion (4). The proponents of surgical removal of primary lesion report that this approach provides highest certainty of protecting patients from the development of life-threatening complications, its is aimed at improving the quality of life and prolonging the survival (5, 6, 7, 8) . Still, surgery is associated with a risk of complications, also fatal ones, and a significant portion of patients at stage IV of colorectal cancer advancement will die due to disease progression before the complications characteristic for the primary lesion can develop (9, 10) . In addition, surgical intervention, by delaying the chemotherapy initiation, may reduce its efficacy (11, 12) . On the other hand, in selected patients, surgical reduction of tumour mass may be associated with an improved response to chemotherapy, as observed in patients with distant metastases of ovarian or renal cancer (13, 14, 15) . One of the objectives of palliative resections in disseminated colorectal cancer is the minimisation of the risk of life-threatening complications associated with the progression of primary lesion, The available non-surgical methods, increasingly more often used, nevertheless have their own limitations, Radiation or laser therapy require repeated treatment cycles and the response remains uncertain. The implantation of self-expandable stents is an effective method of treating gastrointestinal obstruction also enabling to avoid stomas (16, 17). However, the stent implantation does not protect from the occurrence of such symptoms as haemorrhage, pain or empty urgency, often found in patients with advanced colorectal cancer. Surgical excision of the primary lesion seems to be the most effective method enabling local disease control and, by definition, the elimination of the development of complications associated with the growing tumour (18).
In patients treated only with chemotherapy, the development of intestinal complications is often associated with the need for emergency surgery and thus with a higher frequency of non-resection procedures such as bypass or stoma opening. The results of this type of treatment are poorer, and higher mortality and perioperative prevalence rate as compared with the planned resection procedures (19, 20) . The group at particular risk of gastrointestinal obstruction are the patients with diagnosed omental or peritoneal metastases (21).
The presented results of treatment of patients with disseminated rectal cancer do not deviate from those available in literature. The median survival was 16.3 months. Low (1.9%) perioperative mortality was seen and complications were observed in 29% of patients, with no defunctioning stoma. However, it should be stated that the low early mortality and acceptable prevalence of perioperative complications stem not only from the properly performed procedure but also from a highly selective choice of patients.
The decision of performing the synchronous hepatectomy in 17.3% of patients was influenced by the determined pre-and perioperatively possibility of performing a rapid and safe 9 R0 resection (advantageous location -convenient access to the vertical incision and small scope of resected parenchyma). In the study published by Law and colleagues enrolling a group of 70 patients with disseminated rectal cancer treated by resection, early mortality stood at 4.3% while the median survival excluding the perioperative fatalities was 15.2 months. Perioperative complications were found in 42% of patients, while dysfunctional stoma in 7.5% (18).
In the study by Nash and colleagues, presenting the results of surgical treatment of 80 patients with rectal cancer at stage IV of advancement the perioperative mortality was 1.3% and the median survival stood at 25 months. Surgical complications were found in 15% of patients (22).
Evans and colleagues analysed the results patients with generalised colorectal cancer.
In the group of patients treated by resection, the median survival was 11 months. Early survival among the patients who had undergone planned surgery was 14%, while for emergency surgery it stood at 18%. In addition, the authors found that patients treated as emergency cases needed the stoma more often than those undergoing planned treatment: 53% and 32%, respectively (23).
Benoist and colleagues judged that the median survival of patients with colorectal cancer at stage IV of clinical advancement was 23 months, as compared with the median of 22 months in the group of patients undergoing chemotherapy. 6 patients among the 32 treated by surgery developed complications associated with the undergone procedure. The authors conclude that non-surgical approach and early chemotherapy is the treatment of choice in patients with colorectal cancer and nonresectable liver metastases (11) .
On the other hand, Kaufman and colleagues, in a retrospective study evaluating the effects of palliative resection on the survival of patients with advanced colorectal cancer, found a longer median survival of patients treated by surgery and chemotherapy as compared with those receiving chemotherapy only: 30 and 15 months, respectively. In the summary, the authors suggest a beneficial impact of resection on the survival of patients with advanced colorectal cancer, yet due to the methodological imperfections the formulation of binding conclusions is not justified (15) .
Patients with colorectal cancer at stage IV of disease advancement constitute a heterogeneous group in terms of the general condition, nutritional status, the number and localisation of metastases, peritoneal involvement, local advancement of the tumour and coexisting diseases. The decision on the performance of resection in asymptomatic patients is difficult in such cases and based on the analysis of all available data, optimally by a multi-specialist team of physicians, and is associated with the need for individualisation of indications.
In future, it seems necessary to conduct randomised prospective studies evaluating the role of surgical treatment in a group of asymptomatic patients with disseminated colorectal cancer, which would unambiguously determine the legitimacy of such an approach. CONCLUSIONS 1. In a well selected group of patients with disseminated rectal cancer, elective resection may be a procedure of low mortality and acceptable number of complications. 2, This procedure enables the avoidance of potential complications stemming from the local tumour growth.
